Extracorporeal treatment for acetaminophen poisoning: Recommendations from the EXTRIP workgroup

Clinical Toxicology

Volumn 52, Issue 8, 2014, Pages 856-867

  Gosselin, S ^a   Juurlink, D N ^b   Kielstein, J T ^c   Ghannoum, M ^d   Lavergne, V ^e   Nolin, T D ^f   Hoffman, R S ^g  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^f PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetaminophen; Dialysis; Extracorporeal; Guidelines

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL;

ACETAMINOPHEN POISONING; ARTICLE; CASE STUDY; CONSENSUS; DELPHI STUDY; DRUG INTOXICATION; EVIDENCE BASED PRACTICE; FATALITY; HEMODIALYSIS; HUMAN; LIVER FAILURE; METABOLIC ACIDOSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; BLOOD; DIALYSIS; DRUG OVERDOSE; EXTRACORPOREAL; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; REVIEW; STANDARD; TOXIC HEPATITIS;

ACETAMINOPHEN; DIALYSIS; EXTRACORPOREAL; GUIDELINES;

ACETAMINOPHEN; ACETYLCYSTEINE; DRUG OVERDOSE; DRUG-INDUCED LIVER INJURY; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS;

EID: 84907063061     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.946994     Document Type: Article

References (68)

1. Ghannoum M, Nolin TD, Goldfarb DS, Roberts DM, Mactier R, Mowry JB, et al. Extracorporeal treatment for thallium poisoning: recommendations from the EXTRIP Workgroup. Clin J Am Soc Nephrol 2012; 7:1682-1690.
2. Ghannoum M, Nolin TD, Lavergne V, Hoffman RS. Blood purification in toxicology: nephrology's ugly duckling. Adv Chronic Kidney Dis 2011; 18:160-166.
3. Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS, et al. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology. Clin Toxicol (Phila) 2012;50:403-413.
4. Yates C, Galvao T, Sowinski KM, Mardini K, Botnaru T, Gosselin S, et al. Extracorporeal treatment for tricyclic antidepressant poisoning: recommendations from the EXTRIP Workgroup. Semin Dial 2014; 27:381-389.
5. Josephy PD. The molecular toxicology of acetaminophen. Drug Metab Rev 2005; 37:581-594.
6. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers'National Poison Data System (NPDS): 30th Annual Report. Clin Toxicol (Phila) 2013; 51:949-1229.
7. Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc 2014; 89:95-106.
8. Lopez AM, Hendrickson RG. Toxin-induced hepatic injury. Emerg Med Clin North Am 2014; 32:103-125.
9. Bourdeaux C, Bewley J. Death from paracetamol overdose despite appropriate treatment with N-acetylcysteine. Emerg Med J 2007; 24:e31.
10. Schwartz EA, Hayes BD, Sarmiento KF. Development of hepatic failure despite use of intravenous acetylcysteine after a massive ingestion of acetaminophen and diphenhydramine. Ann Emerg Med 2009; 54:421-423.
11. Shah AD, Wood DM, Dargan PI. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol 2011; 71:20-28.
12. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991; 20: 1058-1063.
13. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988; 319:1557-1562.
14. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J Toxicol Clin Toxicol 2002; 40:3-20.
15. Raper S, Crome P, Vale A, Helliwell M, Widdop B. Experience with activated carbon-bead haemoperfusion columns in the treatment of severe drug intoxication. A preliminary report. Arch Toxicol 1982; 49:303-310.
16. Patil N, O'Donnell K, Salhanick S. Prolonged acetaminophen absorption secondary to a possible pharmacobezoar. Clin Toxicol 2009; 47:742.
17. Doyon S, Klein-Schwartz W. Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose. Acad Emerg Med 2009; 16:34-39.
18. Beer C, Pakravan N, Hudson M, Smith LT, Simpson K, Bateman DN, Thomas SH. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. QJM2007; 100:93-96.
19. Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J 2005; 19: 635-637.
20. Adams BK, Mann MD, Aboo A, Isaacs S, Evans A. Prolonged gastric emptying half-time and gastric hypomotility after drug overdose. Am J Emerg Med 2004; 22:548-554.
21. Stork CM, Rees S, Howland MA, Kaplan L, Goldfrank L, Hoffman RS. Pharmacokinetics of extended reliefivs regular release Tylenol in simulated human overdose. J Toxicol Clin Toxicol 1996; 34:157-162.
22. Ho SY, Arellano M, Zolkowski-Wynne J. Delayed increase in acetaminophen concentration after Tylenol PM overdose. Am J Emerg Med 1999; 17:315-317.
23. Milligan TP, Morris HC, Hammond PM, Price CP. Studies on paracetamol binding to serum proteins. Ann Clin Biochem 1994; 31:492-496.
24. Hendrickson R. Acetaminophen. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, eds. Goldfrank's Toxicologic Emergencies. 9th ed. New York, NY: McGraw-Hil; 2013: 483-499.
25. Jaeschke H, Bajt ML. Mechanisms of acetaminophen hepatotoxicity. In: McQueen CA, ed. Comprehensive Toxicology. 2nd ed. Elsevier Ltd. 2010:457-473.
26. Yarema MC, Johnson DW, Berlin RJ, Sivilotti ML, Nettel-Aguirre A, Brant RF, et al. Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med 2009; 54:606-614.
27. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 2006; 89:31-41.
28. Donnelly PJ, Walker RM, Racz WJ. Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxic-ity. Arch Toxicol 1994; 68:110-118.
29. Hinson JA, Pike SL, Pumford NR, Mayeux PR. Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem Res Toxicol 1998; 11:604-607.
30. O'Riordan A, Brummell Z, Sizer E, Auzinger G, Heaton N, O'Grady JG, et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transplant 2011; 26:3501-3508.
31. Breen K, Wandscheer JC, Peignoux M, Pessayre D. In situ formation of the acetaminophen metabolite covalently bound in kidney and lung. Supportive evidence provided by total hepatectomy. Biochem Pharmacol 1982; 31:115-116.
32. Mohandas J, Duggin GG, Horvath JS, Tiller DJ. Metabolic oxidation of acetaminophen (Paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney. Toxicol Appl Pharmacol 1981; 61:252-259.
33. Walker RJ, Fawcett JP. Drug nephrotoxicity-the significance of cellular mechanisms. Prog Drug Res 1993; 41:51-94.
34. Holubek W, Kemp B, Goldfarb D, Nelson L, Hoffman R. The use of extracorporeal techniques in acute acetaminophen (paracetamol) poisoning (abstract). Clin Toxicol 2011; 49:248.
35. Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008; 74:1327-1334.
36. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA 2011. Available from: http://www.rand.org. Accessed July 1, 2014.
37. Grunbaum AM, Kazim S, Ghannoum M, Kallai-Sanfacon MA, Mangel R, Villeneuve E, et al. Acetaminophen and n-acetylcysteine dialysance during hemodialysis for massive ingestion. Clin Toxicol 2013;51:270-271.
38. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991; 303:1026-1029.
39. Gazzard BG, Willison RA, Weston MJ, Thompson RP, Williams R. Charcoal haemoperfusion for paracetamol overdose. Br J Clin Pharmacol 1974; 1:271-275.
40. Higgins RM, Goldsmith DJ, MacDiarmid-Gordon A, Taberner D, Venning MC, Ackrill P. Treating paracetamol overdose by charcoal haemoperfusion and long-hours high-fux dialysis. QJM 1996; 89:297-306.
41. Helliwell M, Essex E. Hemoperfusion in "late" paracetamol poisoning. Clin Toxicol 1981; 18:1225-1233.
42. Ash SR, Caldwell CA, Singer GG, Lowell JA, Howard TK, Rustgi VK. Treatment of acetaminophen-induced hepatitis and fulminant hepatic failure with extracorporeal sorbent-based devices. Adv Ren Replace Ther 2002;9:42-53.
43. Balikova M, Monhart V, Tlustakova M. Scorption efficiency of Czechoslovak haemoperfusion columns'Hemasorb'in toxicological indications. [Czech]. Vnitrni Lekarstvi 1987; 33:772-776.
44. Bentur Y, Zonis Z. Charcoal hemiperfusion in acetaminophen poisoning. [Hebrew]. Harefuah 1984; 107:333-334.
45. Claass A, Gaude M, Schroder H. [Paracetamol poisoning in infancy]. Dtsch Med Wochenschr 1993; 118:898-902.
46. ®) in severe autointoxication. Blood Purif 2010; 30:118-119.
47. Donovan JW, Burkhart KK, O'Donnell S, Shaer A. Hemodialysis for acetaminophen-induced acute liver failure [abstract]. Clin Toxicol (Phila) 2005; 43:433.
48. Eisele G, Bailie GR. Charcoal haemoperfusion to increase paracetamol elimination after overdose. Clin Drug Invest 1995; 10:123-125.
49. Farid NR, Glynn JP, Kerr DN. Haemodialysis in paracetamol self-poisoning. Lancet 1972; 2:396-398.
50. Helliwell M. Severe barbiturate and paracetamol overdose: the simultaneous removal of both poisons by haemoperfusion. Postgrad Med J 1980; 56:363-365.
51. Lai MW, Friedman D, Kalmowitz BD, Niemann P, Curry MP, Burns MM, et al. Extracorporeal Removal of Acetaminophen [abstract]. Clin Toxicol (Phila) 2004;42:748.
52. Lederman S, Fysh WJ, Tredger M, Gamsu HR. Neonatal paracetamol poisoning: treatment by exchange transfusion. Arch Dis Child 1983; 58:631-633.
53. Lieh-Lai MW, Sarnaik AP, Newton JF, Miceli JN, Fleischmann LE, Hook JB, Kauffman RE. Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. J Pediatr 1984; 105:125-128.
54. Pond SM, Tong TG, Kaysen GA, Menke DJ, Galinsky RE, Roberts SM, Levy G. Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophen. J Toxicol Clin Toxicol 1982;19:1-16.
55. Rigby RJ, Thomson NM, Parkin GW, Cheung TP. The treatment of paracetamol overdose with charcoal haemoperfusion and cysteamine. Med JAust 1978;1:396-399.
56. Roberts I, Robinson MJ, Mughal MZ, Ratcliffe JG, Prescott LF. Paracetamol metabolites in the neonate following maternal overdose. Br J Clin Pharmacol 1984; 18:201-206.
57. Wiegand TJ, Margaretten M, Olson KR. Massive acetaminophen ingestion with early metabolic acidosis and coma: treatment with IV NAC and continuous venovenous hemodiafltration. Clin Toxicol (Phila) 2010; 48:156-159.
58. Wu ML, Tsai WJ, Deng JF, Yang CC. Hemodialysis as adjunctive therapy for severe acetaminophen poisoning: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1999; 62:907-913.
59. Sivilotti ML, Good AM, Yarema MC, Juurlink DN, Johnson DW. A new predictor of toxicity following acetaminophen overdose based on pretreatment exposure. Clin Toxicol (Phila) 2005; 43: 229-234.
60. Chomchai S, Chomchai C, Anusornsuwan T. Acetaminophen psi parameter: a useful tool to quantify hepatotoxicity risk in acute acetaminophen overdose. Clin Toxicol (Phila) 2011; 49:664-667.
61. Oie S, Lowenthal DT, Briggs WA, Levy G. Effect of hemodialysis on kinetics of acetaminophen elimination by anephric patients. Clin Pharmacol Ther 1975; 18:680-686.
62. Marbury TC, Wang LH, Lee CS. Hemodialysis of acetaminophen in uremic patients. Int J Artif Organs 1980; 3:263-266.
63. Sivilotti ML, Juurlink DN, Garland JS, Lenga I, Poley R, Hanly LN, Thompson M. Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila) 2013; 51:855-863.
64. Cohen SD, Khairallah EA. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 1997; 29:59-77.
65. Miners JO, Drew R, Birkett DJ. Mechanism of action of paracetamol protective agents in mice in vivo. Biochem Pharmacol 1984; 33: 2995-3000.
66. Prescott LF, Roscoe P, Wright N, Brown SS. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdos-age. Lancet 1971; 1:519-522.
67. Orozco BS, Gray Iii T, Setzer SC, Cole JB. Redistribution of acetaminophen following hemodialysis in the setting of massive overdose. Clin Toxicol 2013; 51:608.
68. Hernandez SH, Howland MA, Schiano T, Hoffman RS. Pharmacoki-netics of N-acetylcysteine during renal replacement therapies (RRTs). Clin Toxicol 2013;51:579.